Caitong International Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Caitong International Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-294	Closed	-$64.9K	–	2657
2025 Q4	$64.9K	Buy	+294	New	+$47.5K	0.02%	603

Caitong International Asset Management's CDTX Position: Q1 2026 in Review

Caitong International Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 294 shares — an estimated $64.9K sold.

Caitong International Asset Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $64.9K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Caitong International Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Caitong International Asset Management sold 294 Cidara Therapeutics shares in Q1 2026, an estimated $64.9K.
Caitong International Asset Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Caitong International Asset Management's Cidara Therapeutics position peaked at $64.9K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.